Effects of probucol on vascular remodeling after coronary angioplasty. Multivitamins and Protocol Study Group.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Circulation

• Publication date

  1999-01-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.99.1.30PMID 9884376
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effectiveness of an antioxidant in preventing restenosis after percutaneous transluminal coronary angioplasty: the Probucol Angioplasty Restenosis Trial.

  1997cited by this paper
• Probucol and multivitamins in the prevention of restenosis after coronary angioplasty.

  1997cited by this paper
• Remodeling of human coronary arteries undergoing coronary angioplasty or atherectomy.

  1997cited by this paper
• Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group.

  1997cited by this paper
• Determinants and correlates of target lesion calcium in coronary artery disease: a clinical, angiographic and intravascular ultrasound study.

  1997cited by this paper
• Effectiveness of probucol in preventing restenosis after percutaneous transluminal coronary angioplasty.

  1996cited by this paper
• Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.

  1996cited by this paper
• Fibromuscular hyperplasia and thrombosis are the predominant mechanisms for late luminal narrowing after balloon angioplasty in porcine coronary arteries

  1996cited by this paper
• Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study.

  1996cited by this paper
• Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model

  1995cited by this paper
• Vitamin E inhibits the intimal response to balloon catheter injury in the carotid artery of the cholesterol-fed rat.

  1995cited by this paper
• Effect of alpha-tocopherol on restenosis after angioplasty in a model of experimental atherosclerosis.

  1995cited by this paper
• Quantitative assessment with intracoronary ultrasound of the mechanisms of restenosis after percutaneous transluminal coronary angioplasty and directional coronary atherectomy.

  1995cited by this paper
• Combination of vitamins C and E alters the response to coronary balloon injury in the pig.

  1995cited by this paper
• Restenosis after experimental angioplasty. Intimal, medial, and adventitial changes associated with constrictive remodeling.

  1995cited by this paper
• Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model.

  1994cited by this paper
• Preventive effects of probucol on restenosis after percutaneous transluminal coronary angioplasty.

  1994cited by this paper
• Geometric Remodeling Is Not the Principal Pathogenetic Process in Restenosis After Balloon Angioplasty: Evidence From Correlative Angiographic‐Histomorphometric Studies of Atherosclerotic Arteries in Rabbits

  1994cited by this paper
• Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion.

  1994cited by this paper
• The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. A study in the normal rabbit and the hypercholesterolemic Yucatan micropig.

  1994cited by this paper
• Probucol Decreases Neointimal Formation in a Swine Model of Coronary Artery Balloon Injury A Possible Role for Antioxidants in Restenosis

  1993cited by this paper
• Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by beta-carotene.

  1993cited by this paper
• Vitamin E in human low-density lipoprotein. When and how this antioxidant becomes a pro-oxidant.

  1992cited by this paper
• Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit.

  1992cited by this paper
• Modulation of the physical state of cellular cholesteryl esters by 4,4'-(isopropylidenedithio)bis(2,6-di-t-butylphenol) (probucol).

  1992cited by this paper
• Probucol prevents oxidative injury to endothelial cells.

  1991cited by this paper
• Inhibition by probucol of interleukin 1 secretion and its implication in atherosclerosis.

  1988cited by this paper
• Probucol inhibits oxidative modification of low density lipoprotein.

  1986cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• Studies on the mechanism of action of probucol.

  1986cited by this paper

• Probucol: revisiting as a multifaceted therapeutic agent in atherosclerosis

  2026cites this paper
• Impact of probucol on xanthoma reduction and its role in cardiovascular event prevention in familial hypercholesterolemia patients

  2025cites this paper
• Vascular smooth muscle cells in intimal hyperplasia, an update

  2023cites this paper
• Serial quantitative angiographic study of target lumen enlargement after drug‐coated balloon angioplasty for native coronary artery disease

  2023cites this paper
• Emerging roles of thiol oxidoreductase-dependent mechanisms on vasomotricity regulation

  2022cites this paper
• Targeting smooth muscle cell phenotypic switching in vascular disease

  2021cites this paper
• Possible mechanism of late lumen enlargement after treatment for de novo coronary lesions with drug-coated balloon.

  2020cites this paper
• Current concepts regarding drug dosing for peripheral stents.

  2019cites this paper
• Acute Pulmonary Embolism and 1-Year Outcome: An Epidemiological Study in East of Iran, 2011-2016

  2019cites this paper
• Cholesteryl ester transfer protein: An enigmatic pharmacology - Antagonists and agonists.

  2018cites this paper
• Vascular remodeling: A redox‐modulated mechanism of vessel caliber regulation

  2017cites this paper
• Rationale and Design of the PROSPECTIVE Trial: Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease.

  2016cites this paper
• Peri/Epicellular Protein Disulfide Isomerase Sustains Vascular Lumen Caliber Through an Anticonstrictive Remodeling Effect

  2016cites this paper
• Profile Rationale and Design of the PROSPECTIVE Trial : Probucol Trial for Secondary Prevention of Atherosclerotic Events in Patients with Prior Coronary Heart Disease

  2016cites this paper
• Did we abandon probucol too soon?

  2015cites this paper
• Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

  2014cites this paper
• Pharmacological inhibition of coronary restenosis: systemic and local approaches

  2014cites this paper
• Dissulfeto isomerase proteica como via integrativa entre estresse oxidativo e resposta a proteínas mal-enoveladas na reparação à lesão vascular

  2014influential citation
• Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.

  2013cites this paper
• A Bumpy and Winding but Right Path to Domestic Drug-Eluting Coronary Stents

  2013cites this paper
• Acute Catheter-Based Mechanical Circulatory Support

  2012cites this paper
• Targeted Treatments for Restenosis and Vein Graft Disease

  2012cites this paper
• Succinobucol-Eluting Stents Increase Neointimal Thickening and Peri-Strut Inflammation in a Porcine Coronary Model

  2012cites this paper
• Mechanisms of post-intervention arterial remodelling.

  2012cites this paper
• Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.

  2012cites this paper
• Pharmacological prevention and management of restenosis

  2010cites this paper
• High-density lipoprotein/apolipoprotein A-I infusion therapy

  2009cites this paper
• Molecular mechanisms underlying the antiatherosclerotic and antidiabetic effects of probucol, succinobucol, and other probucol analogues

  2009cites this paper
• Selective thromboxane inhibition after vascular protectant AGI-1067: results of assessment of lipoprotein profiles (ALPS) biomarkers in vitro and in vivo substudy

  2009cites this paper
• The nucleotide analogue 3-deazaadenosine prevents neointima-formation after balloon injury.

  2009cites this paper
• A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.

  2008cites this paper
• Pro-healing drug-eluting stents: a role for antioxidants?

  2008cites this paper
• The CAIRP (CAndesartan for In-stent Restenosis Prevention) Trial--a multicenter study of AT1-receptor blocker therapy in coronary stenting.

  2008cites this paper
• Anti-atherosclerotic and anti-diabetic properties of probucol and related compounds

  2008cites this paper
• Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

  2007cites this paper
• Probucol [4,4′-[(1-Methylethylidene)bis(thio)]bis-[2,6-bis(1,1-dimethylethyl)phenol]] Inhibits Compensatory Remodeling and Promotes Lumen Loss Associated with Atherosclerosis in Apolipoprotein E-Deficient Mice

  2007cites this paper
• Vascular Remodeling: Hemodynamic and Biochemical Mechanisms Underlying Glagov’s Phenomenon

  2007cites this paper
• Inhibits Compensatory Remodeling and Promotes Lumen Loss Associated with Atherosclerosis in Apolipoprotein E-Deficient Mice

  2007cites this paper
• Probucol mediates vascular remodeling after percutaneous transluminal angioplasty via down-regulation of the ERK1/2 signaling pathway.

  2007cites this paper
• Micro-organismos efectivos (EM-X): acción in-vivo sobre aorta de conejos hipercolesterolémicos

  2007cites this paper
• Inhibitors of the Expression of Vascular Cell Adhesion Molecule-1

  2006cites this paper
• Synthetic Antioxidants and Atherosclerosis: Human Studies

  2006cites this paper
• Antioxidants and Restenosis after Percutaneous Coronary Intervention: Human Studies

  2006cites this paper
• Antioxidants and Restenosis after Percutaneous Coronary Intervention: Animal Studies

  2006cites this paper
• Role of Probucol on Endothelial Dysfunction of Epicardial Coronary Arteries Associated With Left Ventricular Hypertrophy

  2006cites this paper
• Different inflammatory response and oxidative stress in neointimal hyperplasia after balloon angioplasty and stent implantation in cholesterol-fed rabbits.

  2006cites this paper
• Inhibition of vascular remodelling in a porcine coronary injury model by herbal extract XS0601

  2006cites this paper
• Extracellular Superoxide Dismutase with Vaccinia Virus Anti-inflammatory Protein 35K or Tissue Inhibitor of Metalloproteinase-1: Combination Gene Therapy in the Treatment of Vein Graft Stenosis in Rabbits

  2006cites this paper
• Addition of the antioxidant probucol to angiotensin II type I receptor antagonist arrests progressive mesangioproliferative glomerulonephritis in the rat.

  2006cites this paper
• Role of probucol in inhibiting intimal hyperplasia after coronary stent implantation: a randomized study.

  2006cites this paper
• Antioxidants: the good, the bad and the ugly.

  2006cites this paper
• Evaluación de la progresión y la regresión de la aterosclerosis coronaria mediante ecografía intravascular. ¿Un nuevo cambio de paradigma?

  2006cites this paper
• [Assessment of progression and regression of coronary atherosclerosis by intravascular ultrasound. A new paradigm shift?].

  2006cites this paper
• The In Vitro Effects of a Novel Vascular Protectant, AGI-1067, on Platelet Aggregation and Major Receptor Expression in Subjects With Multiple Risk Factors for Vascular Disease

  2006cites this paper
• Genetic determinants of vascular remodelling.

  2006cites this paper
• Anti-inflammatory effects of different drugs/agents with antioxidant property on endothelial expression of adhesion molecules.

  2006cites this paper
• The drug-based pipeline against restenosis

  2005cites this paper
• Antioxidants and atherosclerosis: Emerging drug therapies

  2005cites this paper
• Trials Of Oral Drug Therapy To Reduce Restenosis

  2005cites this paper
• Atherosclerosis imaging.

  2005cites this paper
• Are We Over Oxidized? Oxidative Stress, Cardiovascular Disease, and the Future of Intervention Studies with Antioxidants

  2005cites this paper
• Effect of anti-oxidant (carvedilol and probucol) loaded stents in a porcine coronary restenosis model.

  2005cites this paper
• Adenovirus-Mediated Gene Transfer of Superoxide Dismutase and Catalase Decreases Restenosis after Balloon Angioplasty

  2005cites this paper
• Inflammation as a mechanism and therapeutic target for in-stent restenosis

  2005cites this paper
• N-acetyl-cysteine in the prevention of vascular restenosis after percutaneous balloon angioplasty.

  2004cites this paper
• Low flow promotes instent intimal hyperplasia. Comparison with lumen loss in balloon-injured and uninjured vessels and the effects of the antioxidant pyrrolidine dithiocarbamate.

  2004cites this paper
• Probucol Protects Against Smooth Muscle Cell Proliferation by Upregulating Heme Oxygenase-1

  2004cites this paper
• Effect of probucol on neointimal thickening in a stent porcine restenosis model.

  2004cites this paper
• Intravascular ultrasound assessment of atherosclerosis

  2004cites this paper
• Effects of Probucol versus Aspirin and versus Brachytherapy on Restenosis after Femoropopliteal Angioplasty: The PAB Randomized Multicenter Trial

  2004cites this paper
• Long-term treatment with probucol improves endothelial function in patients with coronary artery disease.

  2004cites this paper
• Clinical Trials: Viewpoint

  2004cites this paper
• Effects of lipid-lowering therapy on coronary artery remodeling

  2004cites this paper
• Preclinical restenosis models and drug-eluting stents: still important, still much to learn.

  2004cites this paper
• Gene therapy for restenosis--what now, what next?

  2004cites this paper
• Redox Processes Underlying the Vascular Repair Reaction

  2004cites this paper
• Pharmacologic prevention of both restenosis and atherosclerosis progression: AGI-1067, probucol, statins, folic acid and other therapies

  2003cites this paper
• Inhibition of oxidized LDL aggregation with the calcium channel blocker amlodipine: role of electrostatic interactions.

  2003cites this paper
• Flow-responsive remodeling after angioplasty is enhanced by high cholesterol diet. Prevention with pyrrolidine dithiocarbamate.

  2003cites this paper
• Effects of candesartan and probucol on restenosis after coronary stenting: results of insight of stent intimal hyperplasia inhibition by new angiotensin II receptor antagonist (ISHIN) trial.

  2003cites this paper
• Effects of AGI-1067 and Probucol After Percutaneous Coronary Interventions

  2003cites this paper
• Clinical results with AGI-1067: a novel antioxidant vascular protectant.

  2003cites this paper
• Oxidized low‐density lipoprotein and high‐density lipoprotein cholesterol modulate coronary arterial remodeling: An intravascular ultrasound study

  2003cites this paper
• Probucol Promotes Functional Reendothelialization in Balloon-Injured Rabbit Aortas

  2003cites this paper
• Antioxidants, statins, and atherosclerosis.

  2003cites this paper
• Vascular protectants for the treatment of atherosclerosis

  2003cites this paper
• The Effect of the Probucol-Loaded BiodivYsioTM DD Stent on Inhibition of Neointimal Proliferation in Porcine Coronary Stent Restenosis Model

  2003cites this paper
• Chronic heart rate reduction with ivabradine and prevention of atherosclerosis progression assessed using intravascular ultrasound

  2003cites this paper
• Effect of BO-653 and probucol on c-MYC and PDGF-A messenger RNA of the iliac artery after balloon denudation in cholesterol-fed rabbits.

  2002cites this paper
• Antioxidant Vitamins and Lipid Therapy

  2002cites this paper
• Design features of the Avasimibe and Progression of coronary Lesions assessed by intravascular UltraSound (A-PLUS) clinical trial.

  2002cites this paper
• Imaging of atherosclerosis. Remodelling of coronary arteries.

  2002cites this paper
• Effect of antioxidant probucol for preventing stent restenosis

  2002cites this paper
• Prevention of restenosis with antioxidants: mechanisms and implications.

  2002cites this paper
• Remodelling of Coronary Arteries

  2002cites this paper
• Drug-coated stents

  2002cites this paper
• Effects of plaque composition on vascular remodelling after angioplasty in the MultiVitamins and Probucol (MVP) trial.

  2002cites this paper
• Prevention of Restenosis with Antioxidants

  2002cites this paper
• Antioxidant vitamins and lipid therapy: end of a long romance?

  2002cites this paper
• Molecular Biology of Vascular Remodeling

  2002cites this paper